The global cell therapy market was valued US$ 8.22 Bn in 2021 and poised to grow at significant CAGR nearly 13.3 % over 2022-2028. Rising in the number of medical research facilities and number of clinical trials centers for development of effective and novel medical solutions for patients as early as possible to diagnosis and treatment of chronic disease such as cancer, cardiac abnormalities and others. Furthermore, new innovations, technological advancement in the medical sector, and rising government initiatives for enhancing the better advance medical facilities will propel the market growth. However, high cost of research and low success rate are some of the factors expected to hinder the market growth. This report gives comprehensive outlook on cell therapy across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of type, technology, cell source, application, end-user and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global cell therapy market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global cell therapy market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global cell therapy market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global cell therapy products. This Market is surging owing to frequent acquisitions and launchings by the market players. In 2018, Thermo Fisher Scientific launched an advanced laboratory management system for data integrity and complete regulatory compliance.